Abstract
Genetic alterations underlying the development of cancer include large chromosomal aberrations, such as amplifications, deletions and translocations as well as small changes in sequence, i.e. mutations. Thus, different methods are needed to reveal various types of genetic changes. Fluorescence in situ hybridisation (FISH) is a versatile technique for detecting chromosomal alterations either in cultured cells or even in formalin-fixed paraffin-embedded tissue. For screening mutations, denaturing high-performance liquid chromatography (DHPLC) provides a relatively fast, cheap and sensitive option. The only special requirement is the HPLC equipment suitable for the analysis. As a screening tool, it does not reveal the actual base pair change, which in the end needs to be done by sequencing. FISH and DHPLC can both be utilized in research as well as in clinical diagnostic laboratories.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/ neu oncogene. Science 235:177–182.
Visakorpi T, Hyytinen E, Koivisto P, et al. (1995) In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet9:401–406.
Tomlins SA, Rhodes DR, Perner S, et al. (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310:644–648.
Hollstein M, Sidransky D, Vogelstein B, Harris CC. (1991) p53 mutations in human cancers. Science 253:49–53.
Taplin ME, Bubley GJ, Shuster TD, et al. (1995) Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 332:1393–1398.
Hyytinen E, Visakorpi T, Kallioniemi A, Kallioniemi OP, Isola J. (1994) Improved technique for analysis of formalin fixed paraffin embedded tumors by fluorescence in situ hybridization. Cytometry 16:93–99.
Saramäki O, Willi N, Bratt O, et al. (2001) Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer. Am J Pathol 159:2089–2094.
Thomas RK, Nickerson E, Simons JF, et al. (2006) Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing. Nat Med 12:852–855.
Ainsworth PJ, Rodenhiser DI. (1994) A nonradioactive method for the detection of single-strand conformational polymorphisms (SSCP). Methods Mol Biol 31:205–210.
Ren J. (2000) High-throughput single-strand conformation polymorphism analysis by capillary electrophoresis. J Chromatogr B Biomed Sci Appl 741(2):115–128.
Fodde R, Losekoot M. (1994) Mutation detection by denaturing gradient gel electrophoresis (DGGE). Hum Mutat 3(2):83–94.
Xiao W, Oefner PJ. (2001) Denaturing high-performance liquid chromatography: A review. Hum Mutat 17:439–474.
Waltering KK, Wallén MJ, Tammela TL, Vessella RL, Visakorpi T. (2006) Mutation screening of the androgen receptor promoter and untranslated regions in prostate cancer. Prostate 66(15):1585–1591.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Saramäki, O.R., Waltering, K.K., Visakorpi, T. (2009). Methods for Identifying and Studying Genetic Alterations in Hormone-Dependent Cancers. In: McEwan, I.J. (eds) The Nuclear Receptor Superfamily. Methods in Molecular Biology™, vol 505. Humana Press. https://doi.org/10.1007/978-1-60327-575-0_15
Download citation
DOI: https://doi.org/10.1007/978-1-60327-575-0_15
Publisher Name: Humana Press
Print ISBN: 978-1-60327-574-3
Online ISBN: 978-1-60327-575-0
eBook Packages: Springer Protocols